Positioning your Company for US Investors: Pros and Cons of a US Parent Company

Cheryl V. Reicin is the International Chair of Mintz’s Life Sciences practice and a trusted advisor to life sciences companies and significant investors in the US, Canada, and countries around the globe. She represents biotechnology, medical device, and health technology companies at all stages of their development as well as venture capitalists, investment banks, and academic medical centers.